Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)
Lithium
44.71
(1.97%)
Gold
2,573.10
(0.19%)
Copper
4.07
0.07%
Oil
68.53
0.59%
Bitcoin
87,880.62
(2.89%)
FTSE 100
8,071.19
0.51%
Nikkei 225
38,535.70
(0.96%)
Dow Jones
43,750.73
(0.64%)
Iron Ore
98.45
(2.11%)
USD/AUD
0.64
(0.67%)
Hang Seng
19,435.81
(0.97%)

Mesoblast (ASX: $MSB) files BLA for Ryoncil with FDA

Mesoblast's strategic advancements


Mesoblast (ASX:MSB), a leader in allogeneic cellular medicines, has filed a Biologics License Application for its product Ryoncil with the U.S. FDA. This application targets the treatment of children with steroid-refractory acute graft versus host disease. The FDA's decision is expected by January 7, 2025.

Overview of Mesoblast's quarterly achievements


Mesoblast has made significant strides this quarter, primarily with its BLA filing for Ryoncil with the FDA. This product addresses a critical need in treating pediatric steroid-refractory acute graft versus host disease. The company is strategically positioning itself for a potential product launch by securing financing and establishing a supply chain. Additionally, Mesoblast has reduced its net operating spend by 26% from the previous year, demonstrating financial prudence. The organization is also advancing its other products, Revascor and Rexlemestrocel-L, in various stages of clinical trials and regulatory reviews. With a positive outlook for Ryoncil's approval and a disciplined financial strategy, Mesoblast is poised for significant market impact and continued growth.

Executive insights on Mesoblast's progress


The company is preparing for Ryoncil's potential commercial launch by establishing a supply chain and targeting key pediatric transplant centers. Mesoblast has also secured strategic financing of up to US$50 million through a convertible note agreement to support this launch.

MESOBLAST LIMITED
MSB | ASX | Health Care
1.780(+0%)
At close 13/11 (AEDT)
Market cap
$2.0B
Volume
15,599,748
DY Yield
PE Ratio
52 Week Range
0.255 - 1.83
1YR Return
N / A

0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions